Company · Pointe Claire, Quebec, Canada
Accel Pharma Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 76
- 19 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 77
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ACCEL-DAPAGLIFLOZIN | 02543184 | Marketed | |
| ACCEL-DAPAGLIFLOZIN | 02543192 | Marketed | |
| ACCEL-DULOXETINE | 02522861 | Marketed | |
| ACCEL-DULOXETINE | 02522888 | Marketed | |
| ACCEL-ENTECAVIR | 02479907 | Marketed | |
| ACCEL-HYOSCINE | 02512335 | Marketed | |
| ACCEL-LEFLUNOMIDE | 02478862 | Marketed | |
| ACCEL-LEFLUNOMIDE | 02478870 | Marketed | |
| ACCEL-ONDANSETRON | 02478927 | Marketed | |
| ACCEL-ONDANSETRON | 02478935 | Marketed | |
| ACCEL-ONDANSETRON ODT | 02535319 | Marketed | |
| ACCEL-ONDANSETRON ODT | 02535327 | Marketed | |
| ACCEL-RIZATRIPTAN ODT | 02483270 | Marketed | |
| ACCEL-RIZATRIPTAN ODT | 02483289 | Marketed | |
| ACCEL-SEVELAMER | 02461501 | Marketed | |
| ACCEL-SILDENAFIL | 02479796 | Marketed | |
| ACCEL-SILDENAFIL | 02479818 | Marketed | |
| ACCEL-SILDENAFIL | 02479826 | Marketed | |
| ACCEL-APREMILAST | 02571021 | Approved | |
| ACC-METFORMIN | 02409291 | Cancelled Pre Market | |
| ACCEL PIOGLITAZONE | 02303442 | Cancelled Post Market | |
| ACCEL PIOGLITAZONE | 02303450 | Cancelled Post Market | |
| ACCEL PIOGLITAZONE | 02303469 | Cancelled Post Market | |
| ACCEL-ALENDRONATE | 02401118 | Cancelled Pre Market | |
| ACCEL-ALENDRONATE | 02401126 | Cancelled Post Market | |
| ACCEL-ALENDRONATE | 02401134 | Cancelled Post Market | |
| ACCEL-AMLODIPINE | 02341093 | Cancelled Post Market | |
| ACCEL-AMLODIPINE | 02341107 | Cancelled Post Market | |
| ACCEL-AMLODIPINE | 02398788 | Cancelled Pre Market | |
| ACCEL-ANASTROZOLE TABLETS | 02397692 | Cancelled Pre Market | |
| ACCEL-BICALUTAMIDE TABLETS USP | 02400731 | Cancelled Pre Market | |
| ACCEL-BOSENTAN | 02435403 | Cancelled Pre Market | |
| ACCEL-CANDESARTAN | 02463741 | Cancelled Pre Market | |
| ACCEL-CANDESARTAN | 02463768 | Cancelled Post Market | |
| ACCEL-CANDESARTAN | 02463776 | Cancelled Post Market | |
| ACCEL-CANDESARTAN | 02463784 | Cancelled Post Market | |
| ACCEL-CANDESARTAN/HCTZ | 02463849 | Cancelled Post Market | |
| ACCEL-CANDESARTAN/HCTZ | 02463857 | Cancelled Post Market | |
| ACCEL-CANDESARTAN/HCTZ | 02463865 | Cancelled Post Market | |
| ACCEL-CELECOXIB | 02435632 | Cancelled Post Market | |
| ACCEL-CELECOXIB | 02435640 | Cancelled Post Market | |
| ACCEL-CITALOPRAM TABLETS | 02355248 | Cancelled Post Market | |
| ACCEL-CITALOPRAM TABLETS | 02355256 | Cancelled Post Market | |
| ACCEL-CITALOPRAM TABLETS | 02355264 | Cancelled Post Market | |
| ACCEL-CLONAZEPAM | 02365243 | Cancelled Pre Market | |
| ACCEL-CLONAZEPAM | 02365251 | Cancelled Pre Market | |
| ACCEL-CLONAZEPAM | 02365278 | Cancelled Pre Market | |
| ACCEL-CLOPIDOGREL | 02419963 | Cancelled Post Market | |
| ACCEL-CLOPIDOGREL | 02419971 | Cancelled Pre Market | |
| ACCEL-DONEPEZIL | 02419866 | Cancelled Post Market | |
| ACCEL-DONEPEZIL | 02419874 | Cancelled Post Market | |
| ACCEL-FINASTERIDE TABLETS USP | 02401142 | Cancelled Pre Market | |
| ACCEL-FLUOXETINE | 02400391 | Cancelled Post Market | |
| ACCEL-FLUOXETINE | 02400405 | Cancelled Post Market | |
| ACCEL-LETROZOLE TABLETS USP | 02406330 | Cancelled Pre Market | |
| ACCEL-MONTELUKAST SODIUM TABLETS | 02401150 | Cancelled Pre Market | |
| ACCEL-MYCOPHENOLATE MOFETIL CAPSULES | 02401053 | Cancelled Pre Market | |
| ACCEL-MYCOPHENOLATE MOFETIL TABLETS | 02400723 | Cancelled Pre Market | |
| ACCEL-OLANZAPINE | 02420538 | Cancelled Post Market | |
| ACCEL-OLANZAPINE | 02420546 | Cancelled Post Market | |
| ACCEL-OLANZAPINE | 02420554 | Cancelled Post Market | |
| ACCEL-OLANZAPINE | 02420562 | Cancelled Post Market | |
| ACCEL-OLANZAPINE | 02420570 | Cancelled Post Market | |
| ACCEL-OLANZAPINE | 02420589 | Cancelled Pre Market | |
| ACCEL-QUETIAPINE | 02400340 | Cancelled Post Market | |
| ACCEL-QUETIAPINE | 02400359 | Cancelled Post Market | |
| ACCEL-QUETIAPINE | 02400367 | Cancelled Post Market | |
| ACCEL-QUETIAPINE | 02400375 | Cancelled Post Market | |
| ACCEL-QUETIAPINE | 02400383 | Cancelled Post Market | |
| ACCEL-TOPIRAMATE | 02435330 | Cancelled Post Market | |
| ACCEL-TOPIRAMATE | 02435349 | Cancelled Post Market | |
| ACCEL-TOPIRAMATE | 02435357 | Cancelled Post Market | |
| ACCEL-TROSPIUM | 02492717 | Cancelled Pre Market | |
| PIOGLITAZONE | 02417049 | Cancelled Pre Market | |
| PIOGLITAZONE | 02417057 | Cancelled Pre Market | |
| PIOGLITAZONE | 02417065 | Cancelled Pre Market |
Notices of Compliance
Newest first.
- ACCEL-APREMILASTAugust 26, 2026 · NOC 38171 · Abbreviated New Drug Submission (ANDS)
- ACCEL-DAPAGLIFLOZINNovember 17, 2025 · NOC 36388 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-DAPAGLIFLOZINJune 4, 2025 · NOC 35478 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-ONDANSETRON ODTJune 3, 2025 · NOC 35463 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-DULOXETINEApril 10, 2025 · NOC 35157 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-LEFLUNOMIDEDecember 12, 2024 · NOC 34549 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-ONDANSETRON ODTOctober 30, 2024 · NOC 34374 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-LEFLUNOMIDEJanuary 8, 2024 · NOC 32478 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-DAPAGLIFLOZINNovember 17, 2023 · NOC 32128 · Abbreviated New Drug Submission (ANDS)
- ACCEL-LEFLUNOMIDESeptember 8, 2023 · NOC 31577 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-ONDANSETRON ODTFebruary 9, 2023 · NOC 30093 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ONDANSETRONJuly 4, 2022 · NOC 28514 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-HYOSCINEDecember 2, 2021 · NOC 27149 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-DULOXETINEDecember 2, 2021 · NOC 27150 · Abbreviated New Drug Submission (ANDS)
- ACCEL-SEVELAMERSeptember 24, 2021 · NOC 26739 · Supplement to a New Drug Submission (SNDS)
- ACCEL-RIZATRIPTAN ODTFebruary 25, 2021 · NOC 25288 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-HYOSCINEFebruary 12, 2021 · NOC 25208 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ONDANSETRONJanuary 4, 2021 · NOC 24914 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-SEVELAMERDecember 15, 2020 · NOC 24806 · Supplement to a New Drug Submission (SNDS)
- ACCEL-PILOCARPINEFebruary 6, 2020 · NOC 23182 · Abbreviated New Drug Submission (ANDS)
- ACCEL-TROSPIUMSeptember 30, 2019 · NOC 22718 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ENTECAVIRJune 21, 2019 · NOC 22316 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-RIZATRIPTAN ODTNovember 23, 2018 · NOC 21550 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ENTECAVIRAugust 16, 2018 · NOC 21221 · Abbreviated New Drug Submission (ANDS)
- ACCEL-SILDENAFILAugust 3, 2018 · NOC 21180 · Abbreviated New Drug Submission (ANDS)
- ACCEL-LEFLUNOMIDEJuly 18, 2018 · NOC 21098 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ONDANSETRONJuly 18, 2018 · NOC 21100 · Abbreviated New Drug Submission (ANDS)
- ACCEL-SEVELAMEROctober 11, 2017 · NOC 19901 · New Drug Submission (NDS)
- ACCEL-CANDESARTAN/HCTZMay 9, 2017 · NOC 19278 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CANDESARTANMay 8, 2017 · NOC 19269 · Abbreviated New Drug Submission (ANDS)
- ACCEL QUETIAPINEMarch 2, 2015 · NOC 16673 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-FLUOXETINEFebruary 17, 2015 · NOC 16616 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-ALENDRONATEJanuary 21, 2015 · NOC 16549 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-TOPIRAMATEJanuary 6, 2015 · NOC 16485 · Abbreviated New Drug Submission (ANDS)
- ACCEL-BOSENTANJanuary 6, 2015 · NOC 16486 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CELECOXIBJanuary 6, 2015 · NOC 16489 · Abbreviated New Drug Submission (ANDS)
- ACCEL-OLANZAPINEFebruary 20, 2014 · NOC 15298 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CLOPIDOGRELFebruary 14, 2014 · NOC 15273 · Abbreviated New Drug Submission (ANDS)
- ACCEL-DONEPEZILFebruary 12, 2014 · NOC 15269 · Abbreviated New Drug Submission (ANDS)
- PIOGLITAZONEDecember 9, 2013 · NOC 14999 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACCEL-PIOGLITAZONEDecember 9, 2013 · NOC 15000 · Abbreviated New Drug Submission (ANDS)
- ACC-METFORMINJuly 31, 2013 · NOC 14617 · Abbreviated New Drug Submission (ANDS)
- ACCEL-METFORMINJuly 7, 2013 · NOC 14536 · Abbreviated New Drug Submission (ANDS)
- ACCEL-OLANZAPINE ODTJuly 3, 2013 · NOC 14518 · Abbreviated New Drug Submission (ANDS)
- ACCEL-LETROZOLE TABLETS USPMay 8, 2013 · NOC 14350 · Abbreviated New Drug Submission (ANDS)
- ACCEL-FLUOXETINE CAPSULES BPFebruary 14, 2013 · NOC 14104 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ALENDRONATE SODIUM TABLETSFebruary 13, 2013 · NOC 14081 · Abbreviated New Drug Submission (ANDS)
- ACCEL-FINASTERIDE TABLETS USPFebruary 13, 2013 · NOC 14082 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CANDESARTAN CILEXETIL TABLETSFebruary 13, 2013 · NOC 14083 · Abbreviated New Drug Submission (ANDS)
- ACCEL-QUETIAPINE TABLETSFebruary 13, 2013 · NOC 14084 · Abbreviated New Drug Submission (ANDS)
- ACCEL-MYCOPHENOLATE MOFETIL CAPSULESFebruary 13, 2013 · NOC 14085 · Abbreviated New Drug Submission (ANDS)
- ACCEL-MONTELUKAST SODIUM TABLETSFebruary 13, 2013 · NOC 14086 · Abbreviated New Drug Submission (ANDS)
- ACCEL-MYCOPHENOLATE MOFETIL TABLETSFebruary 13, 2013 · NOC 14087 · Abbreviated New Drug Submission (ANDS)
- ACCEL-BICALUTAMIDE TABLETS USPFebruary 13, 2013 · NOC 14088 · Abbreviated New Drug Submission (ANDS)
- ACCEL-AMLODIPINEJanuary 7, 2013 · NOC 13997 · Abbreviated New Drug Submission (ANDS)
- ACCEL-AMLODIPINEJanuary 7, 2013 · NOC 13998 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ANASTROZOLE TABLETSDecember 21, 2012 · NOC 13953 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ATORVASTATINDecember 21, 2012 · NOC 13958 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CLARITHROMYCINAugust 31, 2012 · NOC 13613 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CIPROFLOXACINFebruary 1, 2012 · NOC 13000 · Abbreviated New Drug Submission (ANDS)
- ACCEL-RISPERIDONEMarch 25, 2011 · NOC 12218 · Abbreviated New Drug Submission (ANDS)
- ACCEL-ENALAPRILMarch 21, 2011 · NOC 12196 · Abbreviated New Drug Submission (ANDS)
- ACCEL-CLONAZEPAMMarch 18, 2011 · NOC 12200 · Abbreviated New Drug Submission (ANDS)
- ACCEL-METFORMINMarch 18, 2011 · NOC 12201 · New Drug Submission (NDS)
- ACCEL-CITALOPRAM TABLETSOctober 1, 2010 · NOC 11776 · Abbreviated New Drug Submission (ANDS)
- ACCEL-TOPIRAMATE TABLETSMay 26, 2010 · NOC 11422 · Abbreviated New Drug Submission (ANDS)
- ACCEL-SIMVASTATINApril 29, 2010 · NOC 11327 · Abbreviated New Drug Submission (ANDS)
- ACCEL-RAMIPRILMarch 16, 2010 · NOC 11143 · Abbreviated New Drug Submission (ANDS)
- ACCEL-AMLODIPINEMarch 2, 2010 · NOC 11103 · Abbreviated New Drug Submission (ANDS)
- ACC-PIOGLITAZONEJanuary 12, 2010 · NOC 10908 · Abbreviated New Drug Submission (ANDS)
- ACCEL-FOSINOPRILJuly 22, 2009 · NOC 10436 · Abbreviated New Drug Submission (ANDS)
- ACCEL-GABAPENTINJuly 22, 2009 · NOC 10437 · Abbreviated New Drug Submission (ANDS)
- ACCEL-PRAVASTATINJuly 22, 2009 · NOC 10438 · Abbreviated New Drug Submission (ANDS)
- ACCEL-RANITIDINEJune 24, 2009 · NOC 10295 · Abbreviated New Drug Submission (ANDS)
- ACCEL-TAMSULOSINFebruary 24, 2009 · NOC 10054 · Abbreviated New Drug Submission (ANDS)
- ACCEL-LISINOPRILFebruary 24, 2009 · NOC 10059 · Abbreviated New Drug Submission (ANDS)
- ACCEL PIOGLITAZONEJanuary 16, 2009 · NOC 9997 · Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.June 18, 2025 · Drugs · Product quality · Type I
- Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concernsJune 17, 2025 · Drugs · Product safety